Ten years ago, the U.S. Supreme Court issued its 5-3 decision in FTC v. Actavis, […]

#179 What Have We Learned From Empirical Studies? Potential Antitrust Concerns Arising From Common Ownership
Posted 1 year ago Tagged agricultural seeds airlines banking cereals common ownership competition data economic principle empirical evidence financial incentives industries investment mechanism pharmaceuticals policy study
There is a growing interest in understanding the “ownership interests hypothesis,” i.e., whether investors holding […]

#114 What Are the Generic and Biosimilar Industries Worried About? Current Competition Law Issues Impacting the Sector.
Posted 3 years ago Tagged biosimilars comfort letter COVID denigration divisional patents European Commission generics patent linkage pharmaceuticals
Generics and biosimilars are an important part of the pharmaceutical landscape in Europe. What are […]

#76 What’s Ahead in Pharmaceutical Antitrust Enforcement? Taking Stock of Key Pharmaceutical Issues and Enforcement Actions
Posted 3 years ago Tagged antitrust biologics daraprim patent wars pay-for-delay pharmaceutical antitrust pharmaceuticals
Although there is little question as to the need for affordable, accessible, and high-quality pharmaceuticals, […]